Serial Number
86278128
Owner
Envision Pharma, Inc.Attorney
Zachary A. AriaFirst Use Date
Jun 7, 2013
Filing Date
May 12, 2014
ENVISION PHARMA GROUP Trademark
Serial Number: 86278128 • Registration: 4775303
Trademark Classes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Zachary A. Aria Blank Rome LLP
One Logan Square
8th Floor
Philadelphia, PA 19103
United States
Trademark Details
Filing Date
May 12, 2014
Registration Date
July 21, 2015
First Use Anywhere
June 7, 2013
First Use in Commerce
June 7, 2013
Published for Opposition
May 5, 2015
Goods & Services
Strategic educational consulting services for the life sciences, pharmaceutical and bio-pharmaceutical industries in the field of medical education, namely, continuing professional educational courses and meetings for Medical Science Liaisons
Strategic business consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of health economics and outcomes research; Strategic business marketing consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of market access communication strategies; Strategic business consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of medical and scientific publication planning
Strategic consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the nature of regulatory compliance consulting in the field of pharmaceutical and bio-pharmaceutical products
Medical and scientific publication planning in the nature of technical writing for others related to pharmaceutical and bio-pharmaceutical products; Design and implementation of software and technology solutions for the life science, pharmaceutical and bio-pharmaceutical industries, for the purpose of creating, communicating, reporting and auditing of scientific information to be publicly disclosed; Design and implementation of software and technology solutions for the life science, pharmaceutical and bio-pharmaceutical industries, for use in grant programs that manages investigator sponsored research, product requests, funding requests, donation requests, decision process workflow, activity monitoring, and management of contractual obligations
